April 27, 2018 / 5:31 AM / a year ago

BRIEF-Daiichi Sankyo to reorganize Kitasato Daiichi Sankyo Vaccine into specialized manufacturing unit

April 27 (Reuters) - Daiichi Sankyo Co Ltd

* Says it plans to reorganize unit Kitasato Daiichi Sankyo Vaccine Co., Ltd. into a unit specializing in manufacturing, effective April 1, 2019

* Says it will establish a Saitama-based wholly owned biotech unit in August

* The manufacturing and production technology functions of Kitasato Daiichi Sankyo Vaccine will be transferred to the new unit on April 1, 2019

* The functions of Kitasato Daiichi Sankyo Vaccine other than manufacturing and production technologies (research and development, quality assurance, sales and etc.) and marketing approvals will be transferred to the co

* Other details will be disclosed later

Source text in Japanese: goo.gl/HARj5T

Further company coverage: (Beijing Headline News)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below